Sernova (TSE:SVA) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Sernova Corp., a clinical-stage biotech leader in cell therapeutics, is set to participate in the H.C. Wainwright 26th Annual Global Investment Conference in New York, including one-on-one investor meetings. The company is advancing its Cell Pouch System, a device aimed at providing a ‘functional cure’ for insulin-dependent diabetes and other chronic diseases, with promising results in a clinical study.
For further insights into TSE:SVA stock, check out TipRanks’ Stock Analysis page.
